4//SEC Filing
Cavan John T 4
Accession 0001104659-21-069938
CIK 0001583771other
Filed
May 19, 8:00 PM ET
Accepted
May 20, 4:35 PM ET
Size
5.7 KB
Accession
0001104659-21-069938
Insider Transaction Report
Form 4
Cavan John T
Chief Financial Officer
Transactions
- Award
Stock Options
2021-05-18+1,200,000→ 1,581,060 totalExercise: $1.70Exp: 2031-05-18→ Common Stock (1,200,000 underlying)
Footnotes (2)
- [F1]Stock Options have been granted subject to stockholder approval of an increase in the shares of common stock issuable pursuant to the 2013 Equity Incentive Plan.
- [F2]400,000 of the stock options vest on 5/18/2022 and the remainder vests monthly in equal amounts over 24 months.
Documents
Issuer
Hepion Pharmaceuticals, Inc.
CIK 0001583771
Entity typeother
Related Parties
1- filerCIK 0001503738
Filing Metadata
- Form type
- 4
- Filed
- May 19, 8:00 PM ET
- Accepted
- May 20, 4:35 PM ET
- Size
- 5.7 KB